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Myotonic Myopathy in a Miniature Schnauzer: Case Report and 
Data Suggesting Abnormal Chloride Conductance Across the 
Muscle Membrane 
Charles H. Vite, Francesca Cozzi, Mark Rich, Alan K. Klide, Susan W. Volk, and Rocco Lombardo 
1-year-old 6.0-kg, sexually intact male Miniature A Schnauzer was examined due to difficulty swallow- 
ing, increased upper respiratory sounds, ptyalism, difficulty 
rising, and a stiff gait. Physical examination revealed en- 
larged skeletal muscles that were painless when palpated. 
Decreased tongue mobility was noted; the tongue appeared 
wide at the base. Inspiratory stridor was present and paral- 
ysis of the vocal folds was noted during laryngeal exami- 
nation under light sedation. The dog showed considerable 
difficulty rising from a sternal position and required ap- 
proximately 45 seconds until it could stand and walk. The 
dog had little difficulty walking but appeared stiff and ex- 
hibited a "bunny-hop" in its hind limbs when running. The 
dog was unable to step onto a 4-inch platform, and when 
placed on the platform appeared unable or unwilling to step 
down. No dimpling of the appendicular muscles was noted 
after percussion. Lateral compression of the tongue caused 
a noticeable dimple that persisted for 30 seconds after pres- 
sure was removed. A myopathy was suspected. Differential 
diagnoses included myotonic myopathy, muscular dystro- 
phy, myositis, lysosomal storage disease, or other inherited 
myopathies. 
A CBC and serum chemistry analysis were unremarka- 
ble. A serum creatine phosphokinase concentration was 466 
U/L (reference range, 25-467 U/L). A urine cortisol to cre- 
atinine ratio was 14.3 (reference range, < 35). An antinu- 
clear antibody titer and Toxoplasma titer were negative. A 
urine metabolic screen, testing for abnormal substrates of 
metabolism, revealed no evidence of a primary metabolic 
disease. Thoracic radiographs, electrocardiography, and 
cardiac ultrasound revealed no cardiac abnormalities. 
Electrodiagnostic testing was performed on the dog after 
induction of anesthesia with 15 mgkg IV Pentothal (thio- 
pental sodium, Abbott Labs, North Chicago, IL) and 0.5 
mg/kg diazepam (Steris Labs, Phoenix, AZ), tracheal in- 
tubation, and maintenance of anesthesia with inhalant iso- 
flurane. While anesthetized, the rectal temperature of the 
dog was maintained between 99°F and 100°F Electromyo- 
graphic examination was recorded using a 20-mm, 26- 
gauge concentric needle electrode inserted into the muscle 
and a digital amplifier (DANTEC, Skovlunde, Denmark). 
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Medicine 
Amplifier filters were 5 kHz to 5 Hz; responses were re- 
corded at a sensitivity of 100 pV/cm and a sweep speed of 
10 milliseconds/cm. Myotonic discharges, sounding like 
several revving motorcycles, were recorded from all mus- 
cles examined including the appendicular muscles, epaxial 
muscles, muscles of the head and neck, laryngeal muscles, 
and tongue. These discharges waxed and waned; their fre- 
quency and amplitude decreased over time with the dis- 
charges ceasing altogether within 25 seconds. Discharges 
from the gastrocnemius muscle are illustrated in Figure 1 
(sensitivity = 0.5 mV/cm, sweep speed = 1 secondkm). 
The temperature of the gastrocnemius muscle was 98.5"E 
as measured by an intramuscular temperature probe (Yellow 
Springs Instruments Co, Inc, Yellow Springs, OH). Cooling 
the gastrocnemius muscle in an ice wrap to an intramus- 
cular temperature of 86°F caused the duration of the myo- 
tonic discharges to increase to 45 seconds after needle in- 
sertion. Nerve conduction velocity testing was performed 
using 12-mm, 20-gauge recording electrodes inserted in an 
interosseous muscle and stimulating the tibial-sciatic nerve 
at the tarsus and ischiatic notch in the hind limb, and stim- 
ulating the ulnar nerve at the elbow and carpus in the fore- 
limb. Stimulus duration was 200 microseconds, filter set- 
tings were 2 kHz to 20 Hz, sensitivity was 2 mV/cm, and 
sweep speed was 2 millisecondskm. Motor nerve conduc- 
tion velocity of the tibial-sciatic nerve (65 dsecond) and 
the ulnar nerve (62 ndsecond) were within normal limits.' 
Repetitive stimulation at 3 Hz of the ulnar nerve while re- 
cording from the interosseous muscle caused no decre- 
mental response. Sensory nerve conduction velocity of the 
radial nerve (200 evoked responses averaged; filter = 2 
kHz to 20 Hz; stimulus rate = 10 Hz; sensitivity = 5 pV/ 
cm; sweep speed = 2 milliseconds/cm) was within normal 
limits (72 ndsecond).' 
Intravenous procainamide hydrochloride (Abbott Labs) 
was administered at 100 mg, and then at 50 mg increments 
over 1 hour. No change was discernible in the intensity or 
duration of the myotonic discharges until a total of 250 mg 
(41.7 mgkg) procainamide was administered, when the am- 
plitude of the initial activity decreased by 25% and the 
duration of the discharges decreased to 10-12 seconds. Se- 
rum concentrations of procainamide are listed in Table 1. 
The QRS, QT, and PR intervals remained within normal 
limits until 200 mg (33.3 mg/kg) procainamide was given 
intravenously. The QT interval was prolonged to 280 mil- 
liseconds after 200 mg was administered, and to 300 mil- 
liseconds after 250 mg intravenous procainamide was ad- 
ministered. The QRS interval increased to 56 msec after 
250 mg procainamide (41.7 mgkg) was administered. No 
changes in heart rate, mean arterial pressure, systolic pres- 
sure, or diastolic pressure were noted during IV procain- 
amide administration. 
A biopsy of the biceps femoris muscle stained with he- 
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rnyopathy. Muscle temperature = 98.5"F; sensitivity = 0.5 mV/cm; sweep speed = 1 secondkm. 
Electromyographic recording of the decrement in myotonic potentials over time in the gastrocnemius muscle of a dog with myotonic 
matoxylin and eosin revealed occasional fibers with internal 
nuclei. Based on these clinical, electrophysiologic, and his- 
tologic findings a diagnosis of myotonic myopathy was 
made. 
Treatment with oral procainamide hydrochloride (Schein 
Pharmaceuticals Inc, Florham Park, NJ) was begun. A dos- 
age of 240 mg (40 mgkg) procainamide every 6 hours 
resulted in significant improvement in clinical signs. The 
dog could rise easily, its gait was less stiff, abnormal upper 
airway sounds resolved, and its ability to eat and drink 
improved markedly. The dog was able to step onto a 4-inch 
platform yet was unable to walk either up or down a flight 
of stairs. Following 1 week of therapy, the serum procain- 
amide concentration was 10.0 p,g/mL 2 hours after oral 
dosing, 9.9 pg/mL 3 hours after dosing, and 8.4 p,g/mL 6 
hours after oral dosing. After 3 weeks of 240 mg oral pro- 
cainamide every 6 hours, a CBC, serum chemistry analysis, 
and electrocardiogram revealed no significant abnormali- 
ties. Doses of procainamide less than 240 mg produced less 
improvement in clinical signs; doses of 300 mg or higher 
produced weakness and lethargy within 2 hours of dosing 
that resolved by the 3rd hour. A significantly greater serum 
concentration was necessary to alter spontaneous electrical 
activity than was necessary to cause improvement in clin- 
ical signs. 
Oral procainamide was discontinued, and oral mexiletine 
hydrochloride (Boehringer Ingelheim Pharmaceuticals Inc, 
Ridgefield, CT) was administered. Two weeks of 50 mg 
(8.3 mgkg) mexiletine every 8 hours resulted in a signifi- 
Table 1. 
venous procainamide administration. 
Serum procainamide concentration after intra- 
Total Dose Administered 
(mg) 
100 150 200 250 
Serum concentration (kg/mL) 34.0 24.8 40.5 54.5 
Improvement in electromyographic 
abnormalitv No No No Yes 
cant improvement in clinical signs; however, the improve- 
ment was no greater than that noted with procainamide. A 
mexiletine serum concentration, 3 hours after dosing, was 
1.4 pglmL. 
Myotonia may result from defective chloride or sodium 
conductance across the muscle membrane.' Defects in chlo- 
ride conductance cause myotonia by resulting in a high spe- 
cific membrane resistance.* A simple in vitro electophy- 
siologic experiment was performed to determine whether 
specific membrane resistance was abnormally increased in 
the affected dog. A glass microelectrode was used to deliver 
a hyperpolarizing constant-current square-wave pulse into 
an external intercostal muscle fiber and the input resistance 
(RJ of the fiber was determined. By determining the mean 
circumference and area of the muscle fibers within the in- 
tercostal biopsy, the mean membrane resistance for unit 
area of fiber surface (R,) was determined by the formula? 
where r is the radius and 185 cm is an estimate of the 
specific axoplasmic resistance., 
The myotonic dog and 2 unaffected mongrel dogs were 
induced with thiopental and maintained under anesthesia 
with isoflurane. External intercostal muscle was excised 
from the 7th-8th intercostal space, making certain that the 
muscle contained tendon at both ends. The biopsy was 
placed in oxygenated phosphate-buffered saline and trans- 
ported to the electrophysiologic recording chamber within 
15 minutes. The external intercostal muscle biopsy was 
pinned at resting length and continuously perfused with a 
solution containing 108 mmol/L NaCl, 3.5 mmol/L KC1, 
1.5 mmol/L CaCl,, 0.7 mmol/L MgSO,, 26.2 mmol/L 
NaHCO,, 1.7 mmol/L NaH,PO,, 9.6 mmol/L sodium glu- 
conate, and 5.5 mmol/L glucose. The solution was vigor- 
ously aerated with 95% 0, and 5% CO,. Recordings were 
performed at room temperature (1 8-22°C). Microelectrodes 
were filled with 3 M KC1, and only those with resistances 
between 5 and 7 megaohms were used. A single electrode 
was used to give a 10-nA hyperpolarizing pulse lasting 100 
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milliseconds. This allowed the membrane potential to reach 
steady state during the pulse. No voltage offset occurred at 
the beginning of the current pulse. The membrane potential 
was recorded before and during the current pulse. The same 
electrode was used to pass current and to record the change 
in membrane potential using a Model 1600 Neuroprobe am- 
plifier (AM Systems, Washington, DC). The offset in mem- 
brane potential was used to calculate the input resistance 
using the equation V = IR, where V = the offset in mem- 
brane potential; I = 10 nA current; and R = input resis- 
tan~e.’ ,~ Ten to 20 muscle fibers were examined in each 
preparation; only fibers with a resting membrane potential 
of at least -50 mV or more negative were examined. 
Insertion of the glass microelectrode into a myotonic fi- 
ber caused repetitive firing of the fiber that subsided within 
15 seconds. The R,, of the intercostal muscle from the my- 
otonic dog was 0.98 2 0.29 megaohms. The R,, of the 
intercostal muscle from the nonmyotonic dogs was 0.46 ? 
0.19 megaohms and 0.28 mV ? 0.035 megaohms. 
At the time of muscle biopsy, a 2nd intercostal muscle 
section was snap-frozen in isopentane precooled in liquid 
nitrogen, cryosectioned, and stained with hematoxylin and 
eosin. At a magnification of 500X an image of muscle in 
cross-section was digitized and the area and circumference 
of 20 fibers was measured using a tablet pen (Jandel Sci- 
entific, San Rafael, CA) and computer monitor to outline 
the perimeter of muscle fibers. A computer program was 
developed to determine the circumference and area. The 
mean fiber circumference and standard deviation of the my- 
otonic dog was 181 2 29.5 pm; the mean muscle fiber area 
was 2,108 ? 653 pmZ. The mean fiber circumference of 
the 1st unaffected dog was 135 ? 14.6 prn, and of the 2nd 
unaffected dog was 130 ? 18.8 pm; the mean muscle fiber 
area of the 1st unaffected dog was 1,234 2 310 pm2 and 
of the 2nd unaffected dog was 1,135 2 339 pm’. Calcu- 
lated R,, for muscle fiber from the myotonic dog was 7,849 
cmz. Averaged R, for the 2 nonaffected dogs was 504.5 
cm?. 
Myotonia is a clinical sign characterized by delayed re- 
laxation of skeletal muscle after contraction associated 
with persistent repetitive electrical activity in the involved 
muscle.’ Myotonia may result from a defect in either chlo- 
ride or sodium conductance,? and mutations within the 
skeletal chloride and sodium channels have been identified 
as the cause of many of the various forms of myotonia in 
Myotonia may also result from the administra- 
tion of hypocholesterolemic drugs in humans,z and from 
excessive circulating steroid or certain pesticides in dogs.’ 
No evidence was found of excessive circulating steroid in 
the myotonic dog and the dog had no history of toxin 
exposure. 
The very large R, in the myotonic dog, when compared 
to the R,, of the nonmyotonic mongrel dogs, suggests a 
drastic reduction in resting membrane conductance. In 
mammalian muscle fibers, 70-80% of total resting mem- 
brane conductance is due to chloride ion conductance, and 
potassium ion conductance accounts for the remaining 20- 
30%.2,6 Therefore, a large decrease in resting membrane 
conductance is only possible if a concomitant decrease oc- 
curs in chloride conductancez; this can be determined by 
calculating the membrane resistance per unit area of fiber 
s ~ r f a c e . ~ . ~  The R ,  in this myotonic dog is similar to that 
found in external intercostal muscle of humans with myo- 
tonia congenita and is slightly higher than that found in 
myotonic intercostal fibers from goats.8 Although the R,s 
of muscle fibers of nonmyotonic dogs are lower than those 
calculated from external intercostal muscle of normal hu- 
mans (2,200 2 223 cmz) and goats (1,897 ? 86 they 
are similar to that determined in rat m u s ~ l e . ~  The low R, 
in our nonmyotonic dogs may reflect differences between 
speciesx, sampling error due to the small number of non- 
myotonic dogs and muscle fibers examined, or differences 
in the techniques used to determine the R,. 
The purpose of this paper was to present preliminary data 
on a defect in chloride conductance in a dog with myotonic 
myopathy. It must be noted, however, that the 2-electrode 
technique that is the standard for recording membrane phys- 
iology was unavailable to the authors, who used a single- 
electrode recording technique. The goal was to determine 
whether a significant difference in R, occurred between 
normal dog muscle and muscle from the dog with myotonic 
myopathy. Using the same single-electrode technique for 
both the affected and unaffected dogs, a profound differ- 
ence in R, was identified. Rather than pursue more precise 
electrophysiologic evaluation of chloride conductance in 
the muscle membrane using a 2-electrode technique, the 
canine chloride channel is being cloned and evaluated to 
screen for abnormalities. 
Tests to identify abnormalities in sodium ion conductance 
were not performed. Electrophysiologic testing for abnor- 
malities in sodium channel conductance require patch 
clamp or 3-electrode voltage clamp studies; this equipment 
was unavailable. However, a sodium channel defect is un- 
likely to be concomitantly present in this dog because, in 
humans, the sodium channel is encoded by a different gene 
than the chloride channeL6 However, a defect in sodium 
conductance possibly also exists in this dog. 
A significantly larger muscle fiber circumference and 
area was found in the myotonic dog when compared to the 
nonmyotonic dogs. This increase in fiber size is also de- 
scribed in myotonic humans and goats8 and may result from 
isometric contraction due to the my~tonia,*.~ or from dif- 
ferences in size of muscle fibers between different dog 
breeds. No significant difference in weight was found be- 
tween the Miniature Schnauzer and the mongrel dogs ex- 
amined. 
Finally, this report documents the serum concentrations 
of 2 drugs used in the treatment of myotonia. Unfortunately, 
no effective and safe drugs exist that act directly on the 
chloride channel.z Because repetitive activation of the so- 
dium channel is thought to be the underlying cause of the 
repetitive electrical activity in all forms of myotonic mus- 
cle,? therapy is directed at sodium channel blockade. Local 
anesthetic drugs in the class 1 antiarrhythmic category af- 
fect sodium channel activation and decrease net sodium in- 
flux during depolarization.* Procainamide (a class 1A an- 
tiarrhythmic) and mexiletine (a class 1B antiarrhythmic) 
have both been used in the treatment of myotonia in human 
patients.2 In the myotonic dog, clinical signs markedly im- 
proved with a serum procainamide concentration of 10 pg/ 
mL. However, electromyographic abnormalities did not im- 
prove until a serum concentration of 54.5 pg/mL was 
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achieved, and this was accompanied by abnormalities on 
the electrocardiogram consistent with those noted with in- 
creasing procainamide concentrations.10 The electromyo- 
graphic abnormalities noted in the presence of 10 kg/mL 
procainamide may explain why clinical signs did not com- 
pletely resolve in this dog when treated with oral procain- 
amide. A serum mexiletine concentration of 1.4 pglmL was 
found to result in similar improvement but not resolution 
of clinical signs. Class 1B antiarrhythmics have minimal 
effects on cardiac impulse generation and propagation. l o  
Higher doses of mexiletine were postulated to possibly re- 
sult in the further improvement in clinical signs, without 
signs of electrocardiographic abnormalities. However, the 
concern of the owner about administering a drug infre- 
quently used in veterinary medicine limited its use in this 
dog. 
Acknowledgments 
We acknowledge the assistance of Dr R. Barchi, Dr C. 
Otto, Dr K. Braund, Dr U. Giger, Mr J. Hayden, and Dr D. 
Patterson. The housing, care, and examination of dogs was 
performed at the Veterinary Hospital of the University of 
Pennyslvania. In vitro electrodiagnostic examination was 
performed in the laboratory of Dr R. Barchi at the Hospital 
of the University of Pennsylvania. This work was supported 
by National Institutes of Health grant RR025 12. 
References 
1. Bowen JM. Electromyography. In: Oliver JE, Hoerlein BE May- 
hew IG, eds. Veterinary Neurology. Philadelphia, PA: WB Saunders 
Co; 1987:166. 
2. Barchi RL. Myotonia. Neurol Clin 1988;6:473-484. 
3. Kuffler SW, Nicholls JC, Martin AR. From Neuron to Brain, 2nd 
ed. Sunderland, MA: Sinaueer Assoc Inc; 1984: 170-172. 
4. Farnbach GC, Barchi RL. Determination of muscle cable param- 
eters from a single membrane voltage response. J Memhr Biol 1977; 
32: 133-149. 
5.  Gustafsson B, Pinter MJ. Relations among passive electrical 
properties of lumbar alpha motoneurones of the cat. J Physiol 1984; 
3S6:401-43 1. 
6. Hudson AJ, Ebers GC, Bulman DE. The skeletal muscle sodium 
and chloride channel diseases. Brain 1995; 1 18547-563. 
7. Braund KG. Clinical Syndromes in Veterinary Neurology, 2nd 
ed. St Louis, MO: Moshy-Year Book Inc; 1994:195-196. 
8. Lipicky RJ, Bryant SH, Salmon JH. Cable properties, sodium, 
potassium, chloride, and water content, and potassium efflux in iso- 
lated external intercostal muscle of normal volunteers and patients 
with myotonia congenita. J Clin Invest 1971;50:2091-2103. 
9. Swash M, Schwartz MS. Neuromuscular Diseases-A Practical 
Approach to Diagnosis and Management. Berlin, Germany: Springer- 
Verlag; 1981:194. 
10. Lunney J, Ettinger SJ. Cardiac arrhythmias. In: Ettinger SJ, 
Feldman EC, eds. Textbook of Veterinary Internal Medicine. Phila- 
delphia, PA: WB Saunders Co; 1995:987-992. 
